149 of 1195 stocks · SEC-grounded quality, value & health filters. Showing the top 100 — refine or export the full set.
| Ticker | Sector | Mkt cap | P/E | EV/EBITDA | PEG | FCF yield | Div yield | Fair value | Band |
|---|---|---|---|---|---|---|---|---|---|
| INCY | Health Care | $23.3B | 18.2 | 24.9 | 0.0 | 5.7% | — | +108.4% | undervalued |
| EXEL | Health Care | $13.6B | 20.1 | 14.7 | 0.4 | 6.5% | — | +89.1% | undervalued |
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| TGTX |
| Health Care | $8.16B | 19.2 | 67.5 | 0.0 | -0.3% | — | +97.4% | undervalued |
| JNJ | Health Care | $633B | 23.8 | 22.5 | 0.3 | 3.1% | — | +59.3% | undervalued |
| SOLV | Health Care | $13.6B | 8.8 | 6.6 | 0.0 | -0.1% | — | +331.1% | undervalued |
| UTHR | Health Care | $23.6B | 20.0 | 14.0 | 1.7 | 4.4% | — | +46.0% | undervalued |
| AMGN | Health Care | $202B | 26.3 | 17.4 | 0.3 | 4.0% | 2.5% | +44.5% | undervalued |
| MRK | Health Care | $310B | 17.8 | — | 2.7 | 4.0% | 2.6% | -6.1% | fair |
| NBIX | Health Care | $17.5B | 37.3 | 27.0 | 0.9 | 4.3% | — | +1.8% | fair |
| VRTX | Health Care | $134B | 34.5 | 29.4 | 0.0 | 2.4% | — | +10.2% | fair |
| PTCT | Health Care | $6.91B | 10.7 | 7.2 | 0.0 | 10.2% | — | +254.9% | undervalued |
| GMED | Health Care | $10.9B | 20.4 | 13.7 | 0.0 | 5.4% | — | +85.9% | undervalued |
| GILD | Health Care | $163B | 19.4 | — | 0.0 | 5.8% | 2.5% | +96.3% | undervalued |
| LLY | Health Care | $1.08T | 52.9 | — | 0.6 | — | 0.5% | -28.2% | overvalued |
| KRYS | Health Care | $11.1B | 54.8 | 63.9 | 0.4 | 1.7% | — | -30.7% | overvalued |
| DGX | Health Care | $23.9B | 24.7 | 13.7 | 1.8 | 5.7% | 1.5% | +12.6% | fair |
| BIO-B | Health Care | $7.93B | 10.6 | 40.5 | 0.1 | 4.7% | — | +256.9% | undervalued |
| ILMN | Health Care | $28.5B | 34.6 | 26.3 | 0.2 | 3.3% | — | +9.8% | fair |
| LGND | Health Care | $6.40B | 52.1 | 83.7 | 0.0 | 0.8% | — | -27.1% | overvalued |
| UHS | Health Care | $9.58B | 6.9 | 5.4 | 0.2 | 8.9% | 0.5% | +454.4% | undervalued |
| BMY | Health Care | $119B | 16.8 | — | 0.1 | 10.8% | 4.3% | +126.2% | undervalued |
| RMD | Health Care | $30.4B | 22.0 | 15.9 | 0.6 | 5.5% | 1.0% | +72.4% | undervalued |
| LH | Health Care | $23.5B | 27.4 | 13.8 | 1.6 | 5.1% | 1.0% | -1.4% | fair |
| KNSA | Health Care | $4.96B | 86.0 | 60.9 | 0.4 | 2.7% | 0.0% | -55.8% | overvalued |
| CI | Health Care | $76.1B | 13.0 | 5.8 | 0.2 | 11.2% | 0.5% | +173.5% | undervalued |
| DXCM | Health Care | $27.5B | 34.1 | 22.8 | 0.8 | 3.9% | — | +11.5% | fair |
| PACS | Health Care | $7.04B | 36.5 | — | 0.1 | — | 0.0% | +4.2% | fair |
| BIO | Health Care | $7.94B | 10.7 | 40.5 | 0.1 | 4.7% | — | +256.5% | undervalued |
| EHC | Health Care | $10.6B | 19.2 | 13.5 | 0.8 | 4.2% | 0.7% | +97.7% | undervalued |
| HQY | Health Care | $7.97B | 38.7 | 18.0 | 0.3 | 5.7% | 0.0% | -1.9% | fair |
| TEVA | Health Care | $40.3B | 28.6 | 21.3 | 0.2 | 2.8% | 0.0% | +30.5% | undervalued |
| MEDP | Health Care | $15.9B | 36.5 | — | 3.2 | 4.3% | — | -12.8% | fair |
| REGN | Health Care | $68.6B | 15.8 | 16.4 | 7.5 | 5.9% | 0.5% | -28.0% | overvalued |
| CHE | Health Care | $6.50B | 26.7 | 16.2 | — | 5.0% | 0.5% | -65.0% | overvalued |
| VEEV | Health Care | $31.3B | 35.4 | 31.9 | 1.3 | 4.5% | — | +7.3% | fair |
| WAT | Health Care | $37.2B | 35.3 | — | 46.9 | 1.4% | — | -53.1% | overvalued |
| STE | Health Care | $21.3B | 27.5 | 14.3 | 1.0 | 4.6% | 1.1% | +29.0% | undervalued |
| ELV | Health Care | $90.7B | 16.6 | 12.9 | — | 3.5% | 1.7% | -20.4% | overvalued |
| HSIC | Health Care | $9.85B | 26.4 | 11.9 | 12.9 | 5.8% | — | -53.0% | overvalued |
| BIIB | Health Care | $31.9B | 24.6 | 9.7 | — | 6.4% | — | -68.9% | overvalued |
| HALO | Health Care | $9.42B | 31.0 | 23.8 | — | 6.8% | — | -49.1% | overvalued |
| BSX | Health Care | $67.1B | 23.3 | 13.9 | 0.4 | 5.5% | 0.0% | +63.3% | undervalued |
| PEN | Health Care | $12.5B | 70.5 | 59.7 | 0.1 | 1.4% | — | -46.1% | overvalued |
| INDV | Health Care | $4.70B | 24.3 | 17.8 | 0.0 | -2.0% | — | +56.6% | undervalued |
| ZTS | Health Care | $31.4B | 12.4 | — | 1.7 | 7.3% | — | +32.6% | undervalued |
| ENSG | Health Care | $9.83B | 28.8 | 17.9 | 1.9 | 5.0% | 0.1% | +18.5% | undervalued |
| WST | Health Care | $25.8B | 53.9 | 33.4 | 265.4 | 1.8% | 0.2% | -75.2% | overvalued |
| BTSG | Health Care | $13.5B | 79.3 | 34.7 | 0.1 | 2.9% | — | -52.1% | overvalued |
| ISRG | Health Care | $151B | 54.1 | — | 2.4 | 1.7% | — | -29.8% | overvalued |
| A | Health Care | $36.9B | 28.6 | 21.8 | 26.3 | 3.1% | 0.8% | -42.0% | overvalued |
| MDT | Health Care | $106B | 22.3 | 13.6 | 7.5 | 5.1% | 3.4% | -23.5% | overvalued |
| AMRX | Health Care | $5.48B | 78.0 | — | 0.5 | 4.9% | 0.0% | -51.3% | overvalued |
| THC | Health Care | $17.5B | 13.2 | 3.4 | — | 14.4% | — | -36.0% | overvalued |
| MDLN | Health Care | $77.0B | — | 27.2 | — | 1.7% | — | — | — |
| TMO | Health Care | $195B | 29.5 | 22.7 | 5.1 | 3.2% | 0.3% | -46.4% | overvalued |
| SYK | Health Care | $125B | 38.9 | 21.2 | 4.6 | 3.4% | 1.0% | -40.3% | overvalued |
| GEHC | Health Care | $29.8B | 14.4 | — | 3.2 | 5.0% | 0.2% | +6.9% | fair |
| LNTH | Health Care | $7.15B | 32.2 | 19.3 | — | 4.8% | 0.0% | -71.0% | overvalued |
| RPRX | Health Care | $33.3B | 32.5 | — | — | — | — | -75.3% | overvalued |
| COR | Health Care | $57.7B | 37.3 | 16.6 | 12.5 | 5.6% | 0.8% | -50.3% | overvalued |
| SHC | Health Care | $5.11B | 66.4 | 17.6 | 0.9 | 2.9% | 0.0% | -43.8% | overvalued |
| IDXX | Health Care | $44.0B | 42.6 | 29.4 | 2.2 | 2.4% | — | -16.5% | overvalued |
| UNH | Health Care | $386B | 32.2 | 18.9 | — | 4.2% | 0.5% | -74.9% | overvalued |
| ALKS | Health Care | $9.10B | 38.2 | 32.0 | — | 5.3% | — | -77.7% | overvalued |
| EW | Health Care | $54.3B | 51.6 | 36.6 | — | 2.5% | — | -83.5% | overvalued |
| ALGN | Health Care | $13.0B | 32.7 | 15.2 | — | 3.8% | — | -74.0% | overvalued |
| BMRN | Health Care | $11.4B | 32.8 | 20.6 | — | 6.4% | — | -76.7% | overvalued |
| ALHC | Health Care | $4.92B | — | 103.4 | — | 2.3% | — | — | — |
| ONC | Health Care | $30.9B | 1566.6 | 46.5 | 10.8 | 3.0% | — | -97.6% | overvalued |
| IQV | Health Care | $34.6B | 26.4 | 14.5 | — | 5.9% | 1.6% | -54.3% | overvalued |
| BDX | Health Care | $43.6B | 27.2 | 12.3 | — | 6.1% | 2.7% | -55.3% | overvalued |
| COO | Health Care | $14.5B | 39.7 | 15.9 | — | 3.0% | 0.0% | -79.7% | overvalued |
| CORT | Health Care | $9.68B | 110.0 | 208.2 | — | 1.5% | — | -92.3% | overvalued |
| HCA | Health Care | $91.1B | 14.5 | — | 0.8 | 8.4% | 0.7% | +87.3% | undervalued |
| MOH | Health Care | $12.0B | 25.8 | 11.8 | — | -5.3% | — | -71.8% | overvalued |
| DHR | Health Care | $140B | 39.2 | 22.4 | — | 3.8% | 0.6% | -80.5% | overvalued |
| ABT | Health Care | $166B | 25.6 | — | — | 4.5% | 2.5% | -66.9% | overvalued |
| HUM | Health Care | $47.6B | 40.3 | 16.4 | — | 0.8% | 0.9% | -68.4% | overvalued |
| RGEN | Health Care | $8.03B | 165.6 | 59.8 | 0.6 | 1.2% | — | -77.4% | overvalued |
| ALNY | Health Care | $41.8B | 134.2 | 72.0 | 0.6 | 1.1% | — | -71.7% | overvalued |
| PFE | Health Care | $139B | 17.9 | — | — | 6.5% | — | -52.5% | overvalued |
| MCK | Health Care | $92.1B | 20.5 | 14.6 | 0.5 | 6.2% | 0.4% | +85.5% | undervalued |
| DVA | Health Care | $15.1B | 23.9 | 8.4 | — | 8.7% | 0.0% | -64.4% | overvalued |
| ZBH | Health Care | $16.9B | 24.6 | 10.9 | — | 8.7% | 1.1% | -69.0% | overvalued |
| ERAS | Health Care | $5.74B | — | — | — | -1.7% | — | — | — |
| CAH | Health Care | $56.0B | 37.0 | 17.9 | 0.4 | 3.3% | 0.9% | +2.6% | fair |
| SYRE | Health Care | $7.52B | — | — | — | -2.2% | — | — | — |
| HIMS | Health Care | $8.52B | 72.2 | 51.8 | 39.1 | 0.7% | — | -47.3% | overvalued |
| BLLN | Health Care | $5.54B | 859.6 | 222.3 | 7.3 | 0.3% | — | -95.9% | overvalued |
| ARWR | Health Care | $11.8B | — | 96.3 | — | 1.3% | — | — | — |
| RVTY | Health Care | $12.7B | 55.0 | 19.7 | — | 4.0% | 0.3% | -86.1% | overvalued |
| MTD | Health Care | $26.4B | 31.1 | — | 44.4 | 3.2% | — | -59.5% | overvalued |
| CVS | Health Care | $134B | 75.3 | 21.2 | — | 5.8% | 2.5% | -90.4% | overvalued |
| ABBV | Health Care | $461B | 110.6 | — | — | 3.9% | 2.5% | -87.3% | overvalued |
| PODD | Health Care | $11.4B | 47.3 | 21.4 | — | 3.3% | — | -82.0% | overvalued |
| TXG | Health Care | $4.95B | — | — | — | 2.6% | — | — | — |
| MIRM | Health Care | $7.66B | — | 3492.4 | — | 0.7% | — | — | — |
| TFX | Health Care | $5.93B | — | 27.7 | — | 0.0% | 1.0% | — | — |
| TECH | Health Care | $11.0B | 154.0 | 51.3 | — | 2.3% | 0.5% | -95.0% | overvalued |
| CNC | Health Care | $33.5B | — | — | — | 12.9% | — | — | — |